| Code | Description | Claims | Bene. Records | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,007 |
4,128 |
$407K |
| S9083 |
Global fee urgent care centers |
3,030 |
2,235 |
$318K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,212 |
1,806 |
$176K |
| 99215 |
Prolong outpt/office vis |
565 |
515 |
$54K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
254 |
254 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
165 |
165 |
$14K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
378 |
308 |
$9K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
78 |
72 |
$5K |
| 94760 |
|
2,129 |
1,780 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
39 |
38 |
$2K |
| 99051 |
|
259 |
227 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
62 |
58 |
$1K |
| 99000 |
|
325 |
300 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
255 |
239 |
$752.95 |
| 93000 |
|
40 |
40 |
$571.25 |
| 96127 |
|
12 |
12 |
$46.68 |
| 99173 |
|
12 |
12 |
$28.56 |